Sellas Life Sciences Group Inc (SLS)
Cash & Short-Term Investments
$138.44M
Quarterly · Period ending: · USD
SLS Cash & Short-Term Investments
Latest reported$138.44Mperiod ending
Latest reported$138.44Mperiod ending
SLS Quarterly Cash & Short-Term Investments ($2.00K → $138.44M)
Quarterly Cash & Short-Term Investments
High-resolution chart · PNG
SLS cash & short-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 138,443,000 | |
| 107,197,000 | |
| 71,893,000 | |
| 44,420,000 | |
| 25,297,000 | |
| 28,397,000 | |
| 13,886,000 | |
| 21,031,000 | |
| 9,147,000 | |
| 18,415,000 | |
| 2,530,000 | |
| 3,969,000 | |
| 13,807,000 | |
| 23,902,000 | |
| 17,125,000 | |
| 21,348,000 | |
| 26,987,000 | |
| 14,252,000 | |
| 21,455,000 | |
| 26,281,000 | |
| 29,917,000 | |
| 28,033,000 | |
| 35,302,000 | |
| 8,203,000 | |
| 3,340,000 | |
| 6,746,000 | |
| 7,277,000 | |
| 9,119,000 | |
| 12,751,000 | |
| 2,576,000 | |
| 5,337,000 | |
| 9,968,000 | |
| 1,349,000 | |
| 3,474,000 | |
| 2,319,000 | |
| 12,914,000 | |
| 18,073,000 | |
| 27,640,000 | |
| 18,083,000 | |
| 24,514,000 | |
| 19,590,000 | |
| 34,709,000 | |
| 29,730,000 | |
| 34,812,000 | |
| 45,279,000 | |
| 52,860,000 | |
| 23,650,000 | |
| 24,647,000 | |
| 39,162,000 | |
| 52,427,000 | |
| 47,787,000 | |
| 54,233,000 | |
| 26,705,000 | |
| 27,190,000 | |
| 35,485,000 | |
| 15,423,000 | |
| 19,228,000 | |
| 8,701,000 | |
| 11,433,000 | |
| 15,693,000 | |
| 17,933,000 | |
| 11,115,000 | |
| 6,891,000 | |
| 8,832,000 | |
| 11,089,000 | |
| 14,854,000 | |
| 5,684,000 | |
| 8,988,000 | |
| 4,362,000 | |
| 7,172,000 | |
| 9,856,000 | |
| 12,679,000 | |
| 15,075,000 | |
| 9,857,000 | |
| 11,715,000 | |
| 14,180,000 | |
| 2,000 |